We are international
Donate
• IMF TV TEXT SIZE   

ASH 2005 Webcast

IMF reports from the 2005 annual meeting of the American Society of Hematology in Atlanta Georgia. In addition to special interviews with the researchers presenting at ASH, a special, CME-accredited program, New Agents andNew Opportunities for Multiple Myeloma - Today and Tomorrow, brought together leading experts to discuss changing clinical practice in the context of new agents and new discoveries.

ASH 2005 Updates

Special Interview With Julian Adams, Developer Of Velcade
Julian Adams, talks about the devlopment of Velcade and his latest work in developing groundbreaking approaches to the treatment of myeloma

ASH 2005 Presentations and Posters
The IMF is pleased to provide you with a broad sampling of myeloma presentations and posters from the 2005 annual meeting of the American Society of Hematology in San Diego, California. We hope you will find this material informative and useful.

New Agents and New Opportunities for Multiple Myeloma
IMF reports from the 2005 annual meeting of the American Society of Hematology in Atlanta Georgia. In addition to special interviews with the researchers presenting at ASH, a special, CME-accredited program, New Agents and New Opportunities for Multiple Myeloma - Today and Tomorrow, brought together leading experts to discuss changing clinical practice in the context of new agents and new discoveries.